LOS ANGELES—Cutting Edge Testing, as a part of its Hepatitis Awareness Month, has announced that starting today and extended for a month and a half—from June 14, through July 31—it will be screen for Hepatitis Bs Antigen and Hepatitis C Antibody, at no additional charge with the regular talent panel. Also, because of the need to understand the consequences of a positive test if one should arise, a physician will be on site at Cutting Edge Testing to discuss any findings with talent.
Performers seeking to be tested are asked to call the CET main office in Sherman Oaks at (818) 386-2132 to find the closest draw station. So far, there are draw stations in Phoenix, Arizona; Seattle, Washington; Orlando, Florida, and many others places around the country. There will normally be a 48-hour turnaround for testing at these draw stations. The main Sherman Oaks office has a 24-hour turnaround and a physician on site.
Cutting Edge Testing offers the FDA-approved Aptima HIV testing, which is APHSS approved. This is the new accepted "Industry Standard" test package (urine gonorrhea, chlamydia, Treponema Pallidum Antibodies [trep sure syphilis] and Aptima HIV testing) with Hepatitis Bs Antigen and C Antibody screening starting June 14 and ending July 31.
Both Hepatitis Bs Antigen and Hepatitis C Antibody will be screened even though Hepatitis C is very rarely transmitted through sexual contact. The regular panel is still the same price and includes screening for Hepatitis Bs Antigen and Hepatitis C Antibody.
On its website Cutting Edge Testing says, "We offer the most current and accurate testing methods available today. The center is overseen by renown infectious disease specialist, Peter V. W. Miao, MD [Pronounced "Me-ow"]. Dr. Miao has over 30 years of clinical HIV experience. Our goal is to detect the presence of HIV as early as possible to prevent the spread of the disease."
Anyone with questions or concerns is encouraged to contact Cutting Edge Testing directly at (818) 386-2132.
